搜索
Search
Banner

CDMO一体化平台(CDMO)

当前位置:
Homepage
/
Integrated CDMO Platform

INTEGRATED CDMO PLATFORM

Service introduction

这是描述信息

API Process R&D

Across All R&D Stages

  • Preclinical
  • Clinical(Stage I~III)
  • Commercial

 

All-Round Service

  • Process R&D
  • Scale up Manufacturing (Including GMP)
  • Global Regulatory Affairs(CMC dossier preparation)

 

All Kinds of Reactions

  • Routine Reactions
  • Asymmetric Catalytic Hydrogenation
  • High Temperature Reactions
  • Low Temperature Reactions

 

流程详解
流程详解
流程详解
流程详解

Reasonable Synthetic Route Design

流程详解

Prompt Process R&D
 

流程详解

Fit for Purpose Process 0 ptimization

流程详解

Process Safety Evaluation
 

流程详解
流程详解
流程详解
流程详解

Stable Commercial Manufacturing&Sustainable Process 0 ptimization

流程详解

Preparation, Purification and Isolation of Impurities
 

流程详解

Study of Critical Process Parameters
 

流程详解

Control Strategy of Starting Materials and Intermediates
 

流程详解

起始物料及中间体
的控制策略

流程详解

关键工艺参数的设定

 

流程详解

杂质的制备及
分离纯化

流程详解

稳定的商业化生产
及持续的工艺优化

Preformulation Study

这是描述信息

Physicochemical Properties

 

  • PKa /LogP, solubility and acid base properties, etc
  • Characterization of solid state properties: crystallinity, crystal form, thermodynamic properties, hygroscopicity, specific surface area, etc 
  • Stability
  • Detection and determination of solvent complexes/hydrates
     
这是描述信息

Single Crystal Culture and Stereostructure Confirmation

 

  • Screening of solvent for single crystal culture
  • Multiple methods to grow single crystals
  • Confirmation of molecular stereostructure 

 

这是描述信息

Polymorphism Screening and Salt Form Selection

 

  • Solid state characterization and quick solubility test of initial compounds
  • Screening test and evaluation of polymorphism and salt forms
  • Further evaluation of selected polymorphs /salt forms

 

这是描述信息

Excipient Compatibility Study

 

  • Compatibility of excipients / formulation under accelerated conditions

 

Formulation Development

这是描述信息

Formulation and Process Development

  • Study on Physicochemical Properties of APl
  • Reverse study on RLD (generics)
  • Formulation Process Development
  • Selection of Packaging Materials/Stability Study
这是描述信息

Scale up, Technical Transfer

  • Parameter Optimization         
  • Process Scale up, Validation          
  • Technical Transfer
这是描述信息

Manufacturing or Transfer of cGMP Clinical Trial

  • Manufacturing of Clinical Batches
  • Stress Testin
  • Stability Study

Analytical Development and Quality Research (GMP)

Method development, validation and release test

  • Content and related substance analysis
  • Chirality
  • Counter ion
  • Dissolution
  • Genotoxic impurity (LC-MS/GC-MS)

 

  • Residual solvent
  • Heavy metal elemental analysis
  • Physicochemical(XRPD/PSD/TGA)
  • Excipient release tes
这是描述信息
这是描述信息

Stability Research

  • Stability research of new active substances and medicinal products

     Stability research under long-term storage and accelerated condition

     Photostablity research

  • Stability research

     Manufacturing process change research

     Forced degradation test/stability evaluation under accelerated condition

 

Impurity Related Service

  • Stability-indicating method development for related substance analysis and method validation
  • Impurity isolation and structure elucidation
  • Impurity standard, labeled compound and metabolite’s synthesis and preparation
  • Impurity standard characterization and qualification
  • Synthetic route evaluation and Genotoxicity prediction
  • GTIs method development, validation and sample test
  • Heavy metal elemental analysis and residual solvent method development, validation and sample test
  • Degradation pathway research of pharmaceutical degradants

 

这是描述信息

Regulatory Affair

The regulatory affair team provides global registration and declaration full process service.

服务特色

Consulting/Gap Analysis
· Global Regulatory Strategies · Application Plan  · Feasibility Assessment 
· Regulatory Guidance for R&D  · Gap Analysis

服务特色

Regulatory Agency Interactions Support
· Pre-IND meeting, etc

服务特色

Writing & Review of Regulatory Documents

 

(Take IND application as an example)

· CMC · Non-clinical · Clinical

服务特色

Application Submission


· Paper or electronic submission to the regulatory authority system: IND, NDA, ANDA, conformance evaluation, etc

Dosage Forms

这是描述信息

口服制剂

片剂

 

速释片(口崩片/分散片)

缓/控释片

肠溶片

 

 

微丸

 

丸芯上药

 

 

胶囊剂

 

硬胶囊

软胶囊

 

 

口服液

 

 

 

 

这是描述信息

透皮给药

软膏剂

硬膏剂

涂剂

这是描述信息

注射剂

注射液

冻干注射剂

这是描述信息

滴眼液

滴眼液

Immediate Release Tablet

Sustained/Controlled Release Tablets Enteric Coated Tablets Drug Layering Hard Capsules
Soft Capsules Oral Liquid Ointments Plaster Paint
Injection Liquid Lyophilized Injection Powder Eye Drops    

 

Experimental Instruments

企业概况
企业概况
企业概况
企业概况
FRD LAB(PART)
High Shear/Mix Granulator(Glatt) Vibration Powder Sifter
Multifunction fluidized bed(Glatt) Single Punch Tablet Press
Granule Milling Machine(Co-mill) Rotary Tablet Press
Granule Sieving Machine(Co-mill) High-efficient Coating Machine
Bulk/Tapped Density Test仪 Blister Packaging Machine(Al/Pvc, Al/Al)
Flowability Tester Softgel Encapsualating Maching
Disintegration Tester Lyophilizer(Christ)
Analytical Equipment(PART)
ICP-MS Optical Rotation Tester(OR)
HPLC Dissolution Tester(DIS)仪
UPLC-MS/MS Infrared Spectrometer(IR)
GC UV-Visible Spectrophotometer
GC-MS Osmotic Pressure Detector
HPLC-HRMS DSC
SEM Laser Particle Size Analyzer

Quality system

Service advantages

ADVANTAGE

Shorten the time to market

Experienced Team Members

Core members come from world-renowned generic as well as innovative drug companies in the U.S. and China, and have been responsible for the development of numerous generic drug and innovative drugs FDA/NMPA/EU/WHO registrations.

Proven track record in API and formulation development, scale up, production technology transfer, and method development and validation

 

企业优势

Integrated Service

Integrated services are provided from the development of API, formulation process development, scale-up production, process verification, BE clinical trial, clinical trial sample analysis, to dossier  preparation and regulatory submission.

Shorten the development cycle, speed up the IND application, improve the probability of passing BE, and reduce the development cost.

 

企业优势

Efficiency, Quality, Customer Experience

Advanced and well-equipped instruments and equipment guarantee the high quality with high efficiency.

Core team members are responsible for project management to achieve the best customer experience.


 

1

Xihua Headquarters

Address:Building 5, 6 and 7, Lane 118, Furonghua Road, Pudong New Area, Shanghai

Learn more>

Business Consulting

China

Tel:+86-21-5808 6608

Email:BD@xihuasci.com

Overseas

Tel:+01-609-921-7115 (US)

Fax:   +01-609-921-7116 (US)

Other Consultations

China

Email:IR@xihuasci.com

Follow Xihua

Copyright ©.2022 Shanghai Xihua Scientific Co.,Ltd. All right reserved 沪ICP备2020032492号-1